Travaux scientifiques

Prof. Dr. Özlem Mutluay Soyer

108 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. MUTLUAY SOYER OZLEM, BARAN BULENT, ORMECİ ASLI CIFCIBASI, SAHİN DAVUT, GOKTURK SUUT, EVİRGEN SAMİ, BASAR RAFET, FIRAT PINAR, AKYUZ FİLİZ, DEMİR KADİR, BESISIK FATİH, KAYMAKOGLU SABAHATTİN, KARACA CETİN. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort study. Medicine (Baltimore). 2017 Jan;96(1):e5513. doi: 10.1097/MD.0000000000005513.

    Source : page de profil sur medicana.com.tr

  2. ORMECİ ASLI, AYDIN YÜCEL, SUMNU ABDULLAH, BATAN BULENT, MUTLUAY SOYER OZLEM, PINARBASI BİNNUR, GOKTURK SUUT, GULLUOGLU MİNE, ONEL DERYA, BADUR SELİM, AKYUZ FİLİZ, KARACA CETİN, DEMİR KADİR, BESISIK FATİH, KAYMAKOGLU SABAHATTİN. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels. Int J Infect Dis. 2016 Nov;52:68-73. doi: 10.1016/j.ijid.2016.09.007.

    Source : page de profil sur medicana.com.tr

  3. KARACA CETİN, DAGLILAR EBUBEKIR, MUTLUAY SOYER OZLEM, GULLUOGLU MİNE, BRUGGE WİLLİAM R. Endoscopic submucosal resection of gastric subepithelial lesions smaller than 20 mm: a comparison of saline solution-assisted snare and cap band mucosectomy techniques.Gastrointest Endosc. 2016 Sep 20. pii: S0016-5107(16)30585-5. doi: 10.1016/j.gie.2016.09.016.

    Source : page de profil sur medicana.com.tr

  4. MUTLUAY SOYER OZLEM, PEHLİVAN ASLI, CIFCIBASI ORMECI, BARAN BULENT, SAHİN TOLGA Rabbit syndrome developing during peginterferon alfa-2a use in chronic hepatitis C. Curr Med Res Opin. 2017 Jan;33(1):55-56. DOI:10.1080/03007995.2016.1233100.

    Source : page de profil sur medicana.com.tr

  5. MUTLUAY SOYER ÖZLEM,BARAN BULENT,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,AYDIN ESRA, ÖNEL DERYA,GÜLLÜOGLU MINE,KARACA ÇETIN,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2016). Comparison of the efficacy of 12 months and

    Source : page de profil sur medicana.com.tr

  6. longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study. Postgraduate Medicine, 1-7., Doi: 10.1080/00325481.2016.1175310.

    Source : page de profil sur medicana.com.tr

  7. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT, EVIRGEN SAMI,BOZBEY HAMZA UGUR,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH, ÖNEL DERYA,GÜLLÜOGLU MINE,BADUR SELIM,KAYMAKOGLU SABAHATTIN (2013). Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B. Antimicrobial Agents and Chemotherapy, 57(4), 1790-1796., Doi: 10.1128/AAC.02600-12.

    Source : page de profil sur medicana.com.tr

  8. BARAN BULENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,ÖNEL DERYA, GÜLLÜOGLU MINE,BADUR SELIM,KAYMAKOGLU SABAHATTIN (2015). Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B

    Source : page de profil sur medicana.com.tr

  9. virus. Liver International, 35(10), 2265-2274., Doi: 10.1111/liv.1283.

    Source : page de profil sur medicana.com.tr

  10. KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,BARAN BÜLENT,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,AYDIN ESRA,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2012). Efficacy of peginterferon alpha treatment for 24 months in chronic delta hepatitis and predictors of response. Antiviral Therapy, 18(4), 561-566.,

    Source : page de profil sur medicana.com.tr

  11. BARAN BÜLENT,GÜLLÜOGLU MINE,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,YESIL SEMEN,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2014). Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C. Journal of Viral Hepatitis, 21(2),

    Source : page de profil sur medicana.com.tr

  12. YILMAZ EMRE,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÖNEL MUSTAFA,ÖNEL DERYA,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN,KARACA ÇETIN (2014). Effects of Polymorphisms in Interferon λ 3(Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection. Clinical Gastroenterology and Hepatology, 12(10), 1753-1758., Doi: 10.1016/j.cgh.2014.01.043.

    Source : page de profil sur medicana.com.tr

  13. ÇIFCIBASI ÖRMECI ASLI,AKYÜZ FILIZ,BULENT BARAN,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,ÖNEL MUSTAFA,ÖNEL DERYA,AGAÇFIDAN ALI,DEMIRCI MEHMET,YEGEN GÜLÇIN,GÜLLÜOGLU MINE,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2016). Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection. European Review for Medical and Pharmacological Sciences.

    Source : page de profil sur medicana.com.tr

  14. ÖRMECI ASLI,EMRENCE ZELIHA,BARAN BULENT,SUUT GÖKTÜRK,MUTLUAY SOYER ÖZLEM, EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN, ÜSTEK DURAN,DEMIR KADIR (2016). Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. European Review for Medical and Pharmacological Sciences.

    Source : page de profil sur medicana.com.tr

  15. DEMIR ABDURRAHMAN,AKYÜZ FILIZ,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ ÜMIT,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,KARACA ÇETIN,DEMIR KADIR,GÜNDOGDU GÖKCEN,GÜLLÜOGLU MINE, ERER SAIT BURAK,KAMALI SEVIL,KAYMAKOGLU SABAHATTIN, BESISIK SELMAN FATIH,GÜL AHMET(2014). Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scandinavian Journal of Gastroenterology, 49(12), 1414-1418., Doi:10.3109/00365521.2014.976838.

    Source : page de profil sur medicana.com.tr

  16. ÖRMECI ASLI,AKYÜZ FILIZ,BARAN BÜLENT,GÖKTÜRK SUUT,ÖRMECI TUGRUL,PINARBASI BINNUR,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,AKYÜZ ÜMIT,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2016). What is the impact of capsule endoscopy in the long term period?. World Journal of Gastrointestinal Endoscopy, 8(7), 344, Doi: 10.4253/wjge. v8.i7.344.

    Source : page de profil sur medicana.com.tr

  17. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,POYANLI ARZU,KARACA ÇETIN (2013). Angiographic embolization of large duodenal varix in a cirrhotic patient. Digestive and Liver Disease, 45

    Source : page de profil sur medicana.com.tr

  18. (5), 437, Doi: 10.1016/j.dld.2012.10.001.

    Source : page de profil sur medicana.com.tr

  19. BARAN BULENT,MUTLUAY SOYER ÖZLEM,KARACA ÇETIN (2013). Terry's nail: an overlooked

    Source : page de profil sur medicana.com.tr

  20. physical finding in cirrhosis. Hepatobiliary & Pancreatic Diseases International, 12(1), 109, Doi:

    Source : page de profil sur medicana.com.tr

  21. 10.1016/S1499-3872(13)60017-X, (Kontrol No: 2701720)

    Source : page de profil sur medicana.com.tr

  22. KARACA ÇETIN,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM (2012). Unusual location of

    Source : page de profil sur medicana.com.tr

  23. polypectomy with an ultra-slim gastroscope: Biliary polyp (with video). Digestive Endoscopy, 24(6), 477-477., Doi: 10.1111/j.1443-1661.2012.01323.x.

    Source : page de profil sur medicana.com.tr

  24. BARAN BULENT,KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,LAÇIN SAHIN,DEMIR KADIR,BESISIK SELMAN FATIH,BOZTAS GÜNGÖR (2012). Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: A case report. Clinics and Research in Hepatology and Gastroenterology, 36(4), 69-70., Doi: 10.1016/j.clinre.2012.01.002.

    Source : page de profil sur medicana.com.tr

  25. BARAN BÜLENT,KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,YÖNAL IPEK,ISIKLAR AYSUN,ÇAKMAK RAMAZAN,NALÇACI MELIHA,DOGAN ÖNER,KAYMAKOGLU SABAHATTIN (2013). Rosai–Dorfman disease with diffuse gastrointestinal involvement. European Journal of Gastroenterology & Hepatology, 25(7), 869-874., Doi: 10.1097/MEG.0b013e32836019f8.

    Source : page de profil sur medicana.com.tr

  26. ASLI ÇIFCIBASI ÖRMECI, EMRENCE ZELIHA, BÜLENT BARAN, SOYER ÖZLEM, GÖKTÜRK SUUT, EVIRGEN SAMI, AKYÜZ FILIZ, KARACA ÇETIN, BESISIK SELMAN FATIH, KAYMAKOGLU

    Source : page de profil sur medicana.com.tr

  27. SABAHATTIN, ÜSTEK DURAN, DEMIR KADIR (2016). Can helicobacter pylori be eradicated with

    Source : page de profil sur medicana.com.tr

  28. high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotipic

    Source : page de profil sur medicana.com.tr

  29. polymorphism?. European Review for Medical and Pharmacological Sciences,

    Source : page de profil sur medicana.com.tr

  30. ÖRMECI ASLI,AKYÜZ FILIZ,BARAN BÜLENT,GÖKTÜRK SUUT,ÖRMECI TUGRUL,PINARBASI BINNUR,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,AKYÜZ ÜMIT,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLUSABAHATTIN,BESISIK SELMAN FATIH (2016). Retention during capsule endoscopy: Is it a real problem in routine practice?. Journal of International Medical Research, Doi: 10.1177 /0300060516645420.

    Source : page de profil sur medicana.com.tr

  31. GÖKTÜRK SUUT,ATAY KADRI,ÖRMECI ASLI,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,KAYMAKOGLU SABAHATTIN (2011). A rare complication of interferon treatment: optic neuropathy. Annals of Gastroenterology.

    Source : page de profil sur medicana.com.tr

  32. AKYÜZ F, MUTLUAY SOYER Ö (2017). Which diseases are risk factors for developing gastroesophageal reflux disease? Akyüz F, Mutluay Soyer Ö. Turk J Gastroenterol.Dec;28(Suppl 1):S44-S47. doi:10.5152/tjg.2017.12. Review

    Source : page de profil sur medicana.com.tr

  33. AKYÜZ F, MUTLUAY SOYER Ö (2017). How is gastroesophageal reflux disease classified? Akyüz F, Mutluay Soyer Ö. Turk J Gastroenterol. Dec;28(Suppl 1):S10-S11. doi: 10.5152/tjg.2017.04. Review.

    Source : page de profil sur medicana.com.tr

  34. EKINCI OMER, BARAN BULENT, ORMECI AC, SOYER OM, GOKTURK S,POYANLI A, AKYUZ F, KARACA C,DEMİR K, KAYMAKOGLU S (2018). Current State and Clinical Outcome in Turkish Patients with Hepatoceluler Carsinoma. World J.Hepatol. Jan 27;10(1):51-61.

    Source : page de profil sur medicana.com.tr

  35. İLİAZ R, AKYÜZ F, YEĞEN G, ÖRMECİ A, GÖKTÜRK S, AKYÜZ Ü, BARAN B, MUTLUAY Ö, EVİRGEN S, KARACA Ç, DEMİR K, BEŞIŞIK F, GÜLLÜOĞLU M, KAYMAKOĞLU S( 2018). Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? Turk J Gastroenterol. Jul;29(4):384-391. doi: 10.5152/tjg.2018.17491.

    Source : page de profil sur medicana.com.tr

  36. GÖKTÜRK S, AKYÜZ F, ARICI S, ALPASLAN B, ÖRMECİ A, SOYER OM, EVİRGEN S, ÇAVUŞ B, ÜZÜM AK, GÜL N, AKYÜZ Ü, KARACA Ç, DEMİR K, KAYMAKOĞLU S, SATMAN İ, BEŞIŞIK F (2018). Gastroesophageal Reflux in Asymptomatic Patients with Diabetes: An Impedance Study Diabetes, Obesity and Gastroesophageal Reflux. Exp Clin Endocrinol Diabetes. 2018 Nov 20. doi: 10.1055/a-0783-2327.

    Source : page de profil sur medicana.com.tr

  37. B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler :

    Source : page de profil sur medicana.com.tr

  38. KARACA ÇETIN,YILMAZ EMRE,MUTLUAY SOYER ÖZLEM,ÖNEL DERYA,ÖNEL MUSTAFA, BARAN BÜLENT,ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis.

    Source : page de profil sur medicana.com.tr

  39. 2.ÖRMECI ASLI,GÖKTÜRK SUUT,AKYÜZ FILIZ,GÜLLÜOGLU MINE,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2012). When we should start antiviral treatment in CMV positive

    Source : page de profil sur medicana.com.tr

  40. inflammatory bowel disease?. UEG WEEK 2012 (Poster).

    Source : page de profil sur medicana.com.tr

  41. DEMIR KADIR,ÖRMECI ASLI,EMRENCE ZELIHA,GÖKTÜRK SUUT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN,ÜSTEK DURAN (2013). Effect of Genotypic Differences in CYP2C19 and on Cure Rates for

    Source : page de profil sur medicana.com.tr

  42. Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors.

    Source : page de profil sur medicana.com.tr

  43. ÖZDIL SADAKAT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,BARAN BÜLENT,GÖKTÜRKSUUT,EVIRGEN SAMI,DEMIR KADIR (2012). Natural course in Crohn’s disease under the conventional Therapy. FALK SYMPOSIUM 2012 (Poster).

    Source : page de profil sur medicana.com.tr

  44. GÖKTÜRK SUUT,BESISIK SELMAN FATIH,ARICI SERPIL,ALPASLAN BÜSRA,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,ÇAVUS BILGER,KUBAT ÜZÜM AYSE,GÜL NURDAN,AKYÜZ ÜMIT, KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,SATMAN ILHAN (2014). Is Diabetes Mellitus a Risk Factor for Gastroesophageal Reflux?. DIGESTIVE DISEASE WEEK 2014 (Poster)

    Source : page de profil sur medicana.com.tr

  45. AKYÜZ FILIZ,ÖRMECI ASLI,KARACA ÇETIN,GÖKTÜRK SUUT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,ÖRMECI TUGRUL,POYANLI ARZU,GÜLLÜOGLU MINE,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). A disease with a wide range of clinical presentation: IgG4 related disease. APASL LIVER WEEK 2013 (Poster)

    Source : page de profil sur medicana.com.tr

  46. GÖKTÜRK SUUT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,BARAN BÜLENT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2016). Efficacy of infliximab treatment in acute severe ulcerative colitis. 8th Congress of ECCO 2013 (Poster).

    Source : page de profil sur medicana.com.tr

  47. BARAN BÜLENT,GÜLLÜOGLU MINE,MUTLUAY SOYER ÖZLEM,ÖRMECI ASLI,GÖKTÜRK SUUT,

    Source : page de profil sur medicana.com.tr

  48. EVIRGEN SAMI,YESIL SEMEN,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU

    Source : page de profil sur medicana.com.tr

  49. SABAHATTIN,BESISIK SELMAN FATIH (2013). Treatment failure may lead to accelerated

    Source : page de profil sur medicana.com.tr

  50. fibrosis progression in patients with chronic hepatitis C. EASL 2013 (Poster).

    Source : page de profil sur medicana.com.tr